Robert H. Carlson

Iowa Dermatology Inc.




New drug targets considered for erectile dysfunction

November 01, 2003

Paris-Basic research in erectile dysfunction therapy is being hamperedby the attitude of some funding bodies that phosphodiesterase type-5 inhibitorsalone have solved all problems, according to a special committee convenedat the 2nd International Consultation on Erectile and Sexual Dysfunctionshere.

HIFU yields 73% cancer-free rate at 6 months

November 01, 2003

Chicago-Treating localized prostate cancer with high-intensityfocused ultrasound (HIFU) appears to be safe, efficacious, and well tolerated,according to data presented by several European research groups at the AUAannual meeting in Chicago.